Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
Keech, AC, Mitchell, P, Summanen, PA, O'Day, J, Davis, TME, Moffitt, MS, Taskinen, M-R, Simes, RJ, Tse, D, Williamson, E, Merrifield, A, Laatikainen, LT, d'Emden, MC, Crimet, DC, O'Connell, RL, Colman, PG
Published in The Lancet (British edition) (17.11.2007)
Published in The Lancet (British edition) (17.11.2007)
Get full text
Journal Article
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
Keech, A, Simes, R J, Barter, P, Best, J, Scott, R, Taskinen, M R, Forder, P, Pillai, A, Davis, T, Glasziou, P, Drury, P, Kesäniemi, Y A, Sullivan, D, Hunt, D, Colman, P, d'Emden, M, Whiting, M, Ehnholm, C, Laakso, M
Published in The Lancet (British edition) (26.11.2005)
Published in The Lancet (British edition) (26.11.2005)
Get full text
Journal Article
Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial
Hooper, M. J., Ebeling, P. R., Roberts, A. P., Graham, J. J., Nicholson, G. C., D'Emden, M., Ernst, T. F., Wenderoth, D.
Published in Climacteric : the journal of the International Menopause Society (01.09.2005)
Published in Climacteric : the journal of the International Menopause Society (01.09.2005)
Get full text
Journal Article
CA-113: Passage de l'insuline basale, deux fois par jour, à une dose quotidienne unique de la nouvelle insuline glargine 300 U/mL (Gla-300). Une analyse chez les patients DT2 (EDITION 1 et 2)
Roussel, R., D'emden, M., Fisher, M., Ampudia-Blasco, F., Stella, P., Grisoni, M., Cali, A., Wysham, C.
Published in Diabetes & metabolism (01.03.2016)
Published in Diabetes & metabolism (01.03.2016)
Get full text
Journal Article
EE548 Healthcare Resource Use and Costs Associated with Oral Antibiotic Treatment Failure in Uncomplicated Urinary Tract Infection in the US
Franklin, M., Sacks, N.C., Emden, M., Kautz, S., Joshi, A.V., Mitrani-Gold, F.S., Preib, M.
Published in Value in health (01.06.2023)
Published in Value in health (01.06.2023)
Get full text
Journal Article
Risk Predictors of Lower-limb Amputation in Patients with Type 2 Diabetes Mellitus in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
Rajamani, K., Li, L., Best, J., Voysey, M., Ting, R., D’Emden, M., Laakso, M., Baker, J., Keech, A.
Published in Heart, lung & circulation (2011)
Published in Heart, lung & circulation (2011)
Get full text
Journal Article
CV3 VARIATIONS IN HEALTHCARE RESOURCE USE AND EXPENDITURES BY AGE IN PATIENTS UNDER AGE 65 NEWLY DIAGNOSED WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) IN THE UNITED STATES
Sacks, N.C., Everson, K.A., Cyr, P.L., Emden, M., Preib, M., Wood, D.R., Pokorney, S.D.
Published in Value in health (01.05.2019)
Published in Value in health (01.05.2019)
Get full text
Journal Article
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, Christoph, Inzucchi, Silvio E, Lachin, John M, Fitchett, David, von Eynatten, Maximilian, Mattheus, Michaela, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Zinman, Bernard
Published in The New England journal of medicine (28.07.2016)
Published in The New England journal of medicine (28.07.2016)
Get full text
Journal Article
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, Bernard, Wanner, Christoph, Lachin, John M, Fitchett, David, Bluhmki, Erich, Hantel, Stefan, Mattheus, Michaela, Devins, Theresa, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Inzucchi, Silvio E
Published in The New England journal of medicine (26.11.2015)
Published in The New England journal of medicine (26.11.2015)
Get full text
Journal Article
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME ® trial
Fitchett, David, Zinman, Bernard, Wanner, Christoph, Lachin, John M., Hantel, Stefan, Salsali, Afshin, Johansen, Odd Erik, Woerle, Hans J., Broedl, Uli C., Inzucchi, Silvio E.
Published in European heart journal (14.05.2016)
Published in European heart journal (14.05.2016)
Get full text
Journal Article
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Wanner, Christoph, Lachin, John M., Inzucchi, Silvio E., Fitchett, David, Mattheus, Michaela, George, Jyothis, Woerle, Hans J., Broedl, Uli C., von Eynatten, Maximilian, Zinman, Bernard
Published in Circulation (New York, N.Y.) (09.01.2018)
Published in Circulation (New York, N.Y.) (09.01.2018)
Get full text
Journal Article
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
Wanner, Christoph, Heerspink, Hiddo J.L., Zinman, Bernard, Inzucchi, Silvio E., Koitka-Weber, Audrey, Mattheus, Michaela, Hantel, Stefan, Woerle, Hans-Juergen, Broedl, Uli C., von Eynatten, Maximilian, Groop, Per-Henrik
Published in Journal of the American Society of Nephrology (01.11.2018)
Published in Journal of the American Society of Nephrology (01.11.2018)
Get full text
Journal Article
EE304 IDegAsp Treatment Was Associated with Reduced Healthcare Resource Utilization in Adults with Type 2 Diabetes: A Real-World Study
Alturaiki, A, Al-Suwairi, M, Akhtar, S, Basse, A, d’Emden, M, Kok, A, Garcia Uranga, J, Snyman, J, Fulcher, G
Published in Value in health (01.07.2022)
Published in Value in health (01.07.2022)
Get full text
Journal Article
Myocardial infarction and type II diabetes - preferential treatment for high risk patients?
Green, B., Duffull, S., Cottrell, N., D'Emden, M.
Published in Journal of clinical pharmacy and therapeutics (01.10.2002)
Published in Journal of clinical pharmacy and therapeutics (01.10.2002)
Get full text
Journal Article